Näytetään tulokset 1 - 10 / 9595
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation

Vertaisarvioitu
DOI
10.21873/anticanres.11242
Joensuu, Timo; Joensuu , Greetta; Kairemo, Kalevi; Kiljunen, Timo; Riener, Maigo; Aaltonen, Aili; Al...
Anticancer research2016

Chemotherapy for Castration Resistant Metastatic Prostate Cancer

Avoin saatavuus
Hervonen Petteri
Acta Universitatis Tamperensis2014

Enzalutamide in metastatic prostate cancer before chemotherapy

Vertaisarvioitu
DOI
10.1056/NEJMoa1405095
Beer Tomasz;  Armstrong Andrew; Rathkopf Dana; Loriot Yohann; Sternberg Cora; Higano Celestia; Ivers...
New England Journal of Medicine2014

Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.euros.2024.10.010
Murtola, Teemu J.; Siltari, Aino; Raittinen, Paavo; Tammela, Teuvo L.J.; Linder, Stig; Csizmarik, An...
European urology open science2024

The evolutionary history of lethal metastatic prostate cancer

Vertaisarvioitu
DOI
10.1038/nature14347
Gundem, Gunes; Van Loo, Peter; Kremeyer, Barbara; Alexandrov, Ludmil B.; Tubio, Jose M.C.; Papaemman...
Nature2015

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/20013078.2017.1354645
Lazaro Ibañez, Elisa; Neuvonen, Katri Maarit; Takatalo-Laine, Sari Maarit; Thanigai Arasu, Uma; Capa...
Journal of extracellular vesicles2017

Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/ijc.33535
Salminen, Jukka K.; Kuoppamäki, Viivu; Talala, Kirsi; Taari, Kimmo; Mäkinen, Jussi; Peltola, Jukka; ...
International journal of cancer2021

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1056/NEJMoa2119115
Smith, Matthew R; Hussain, Maha; Saad, Fred; Fizazi, Karim; Sternberg, Cora N; Crawford, E David; Ko...
The new england journal of medicine2022

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1056/nejmoa1704174
Fizazi, Karim;NamPhuong, Tran;Tran, Nam Phuong;Fein, Luis;Matsubara, Nobuaki;Rodriguez-Antolin, Alf;...
new england journal medicine2017

Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients

Vertaisarvioitu
DOI
10.1159/000493193
Iivanainen, Sanna; Koivunen, Jussi P.
Oncology2019

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation

Vertaisarvioitu
DOI
10.21873/anticanres.11242
2016

Chemotherapy for Castration Resistant Metastatic Prostate Cancer

Avoin saatavuus
2014

Enzalutamide in metastatic prostate cancer before chemotherapy

Vertaisarvioitu
DOI
10.1056/NEJMoa1405095
2014

Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.euros.2024.10.010
2024

The evolutionary history of lethal metastatic prostate cancer

Vertaisarvioitu
DOI
10.1038/nature14347
2015

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/20013078.2017.1354645
2017

Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/ijc.33535
2021

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1056/NEJMoa2119115
2022

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1056/nejmoa1704174
2017

Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients

Vertaisarvioitu
DOI
10.1159/000493193
2019